CHICAGO -- Zacks.com releases the latest Zacks Industry Rank. Stocks featured in this week's analysis include ConAgra Foods (NYSE: CAG), Diamond Foods (Nasdaq: DMND), Lennar (NYSE: LEN), Sara Lee (NYSE: SLE) and Walgreen Co. (NYSE: WAG). To see the Zacks Industry Rank and the trend in earnings estimates
Zacks Industry Rank Analysis is written by Charles Rotblut, CFA, Senior Market Analyst for Zacks.com.
The week between Christmas and New Year's Day is typically a slow period for the financial markets. Compounding matters this year was the day of mourning for President Ford, which resulted in the stock exchanges being closed for four calendar days - a rarity. As a result, there wasn't a material number of estimate revisions.
One stock that did buck the trend, however, was Walgreen Co. (NYSE: WAG). WAG reported just before Christmas and analysts continued to revise their fiscal 2007 estimates last week.
The drug store chain earned 43 cents per share in its fiscal first quarter, two cents above expectations. Total comparable store sales rose 9.7%, paced by a 5.8% jump in front-end comparable drugstore sales. WAG benefited from an increase in pharmacy patients thanks to Medicare Part D. Although reimbursements under the drug benefit are less than the cash price previously paid by patients, the drag on margins are offset by higher volume.
Based on the strong earnings report, analysts now expect WAG to earn $2.03 this fiscal year versus the previous forecast of $1.99 per share. Walgreen's is a Zacks #2 Rank stock and is classified in Retail-Drug Stores.
Another company that reported in late December was ConAgra Foods (NYSE: CAG). The agricultural conglomerate generated a fiscal second-quarter profit of 40 cents per share, six cents above expectations. Improved margins (divestures and cost-cutting) and 10% sales growth in the company's Food and Ingredients segment contributed to the strong performance.
Looking forward, CAG raised its fiscal 2007 profit guidance to a range of $1.28 to $1.33 per share. Five of the eight covering brokerage analysts responded by adjusting their forecasts. The new consensus estimate is slightly above ConAgra's guidance at $1.34 per share.
ConAgra is a Zacks #1 Rank stock and is classified in Food/Miscellaneous-Diversified. The group contains five other Zacks #1 Rank stocks, including Sara Lee (NYSE: SLE) and Diamond Foods (Nasdaq: DMND).
Last week, I discussed the negative trend in earnings estimates among homebuilders. Two days ago, Lennar (NYSE: LEN) added to the bearish sentiment by cutting its fiscal fourth-quarter guidance. Excluding valuation adjustments and write-offs, the company expects to report profits within a range of 70 cents to 75 cents per share. This guidance compares to analyst expectations for profits of $1.05 per share. I would expect the consensus estimate to be cut over the next few days.
The interactive Zacks Industry Rank List allows you to see all of the companies, and their Zacks Rank, within more than 200 industries. See the list at http://at.zacks.com/?id=3208.
About Zacks Industry Rank and the Zacks Rank
Zacks Industry Rank is calculated by averaging the Zacks Rank for all covered companies within a given industry. The Zacks Rank is assigned to approximately 4400 stocks and ranges from #1 ("Strong Buy") to #5 ("Strong Sell"). Both the Zacks Industry Rank and the Zacks Rank are quantitative indicators designed to cover periods of 1-3 months.
Since 1988, the Zacks Rank has proven that "Earnings estimate revisions are the most powerful force impacting stock prices." Since inception in 1988, #1 Rank stocks have generated an average annual return of +31.8%. During the 2000-2002 bear market, Zacks #1 Rank stocks gained +43.8%, while the S&P 500 tumbled -37.6%. Also note that the Zacks Rank system has just as many Strong Sell recommendations (Rank #5) as Strong Buy recommendations (Rank #1). Since 1988, Zacks Rank #5 stocks have underperformed the S&P 500 by 143.6% annually (+4.8% vs. +11.8%). Thus, the Zacks Rank system allows investors to truly manage portfolio trading effectively.
Zacks "Profit from the Pros" e-mail newsletter offers continuous coverage of the industries and the stocks poised to outperform the market. Subscribe to this free newsletter today by visiting http://at.zacks.com/?id=2564.
About Zacks
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros by going to http://at.zacks.com/?id=2565.
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
(a)The Zacks Performance Rank performance is the total return of equal weighted simulated portfolios consisting of those stocks with the indicated Zacks Rank net of fees. Results reflect the reinvestment of dividends and other earnings. Simulated results do not represent actual trading and may not reflect the impact that economic and market factors might have had on decision-making if an adviser were actually managing a client's money.
(b)The S&P 500 Index ("S&P 500") is a well-known, unmanaged index of the prices of 500 large-company common stocks selected by Standard & Poor's. The S&P 500 includes the reinvestment of all dividends, no transaction costs, and represents the gross returns before management fees.
Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.